SCHEMBL6409508

SCHEMBL6409508

COC(=O)NC(CCN1CCC2(CC1)CCN(Cc1ccc(S(C)(=O)=O)cc1)C2=O)c1ccc(OC)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 5/20 0.38
CCR2 P41597 2/20 0.36
PDE4B Q07343 1/20 0.36
ALDH1A1 P00352 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
KDM4E B2RXH2 2/20 0.35
USP2 O75604 1/20 0.35
GAA P10253 1/20 0.35
TSHR P16473 1/20 0.35
KCNH2 Q12809 1/20 0.35
KMT2A Q03164 2/20 0.34
MEN1 O00255 1/20 0.34
MMP1 P03956 2/20 0.34
MMP9 P14780 2/20 0.34
MMP13 P45452 2/20 0.34
ADAM17 P78536 2/20 0.34
ABCB1 P08183 1/20 0.34
RORC P51449 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6409500 0.99 CCR5 (0.38) CCR5CCR2PDE4BALDH1A1SMN1; SMN2
SCHEMBL6412947 0.94 CCR5 (0.39) CCR5CCR2PDE4BALDH1A1KCNH2
Hydrochloric Acid SCHEMBL6412939 0.93 CCR5 (0.39) CCR5CCR2PDE4BALDH1A1KCNH2
SCHEMBL6414389 0.93 CCR5 (0.37) CCR5CCR2PDE4BALDH1A1SMN1; SMN2
SCHEMBL6408943 0.90 CCR5 (0.47) CCR5CCR2SMN1; SMN2KCNH2MMP1
SCHEMBL6416700 0.90 HPGD (0.38) CCR5PDE4BALDH1A1SMN1; SMN2KMT2A
SCHEMBL6411170 0.90 CCR5 (0.44) CCR5CCR2MMP1MMP9MMP13
Hydrochloric Acid SCHEMBL6408939 0.89 CCR5 (0.46) CCR5CCR2KCNH2MMP1MMP9
Hydrochloric Acid SCHEMBL6416695 0.89 HPGD (0.38) CCR5PDE4BALDH1A1SMN1; SMN2KMT2A
Hydrochloric Acid SCHEMBL5256271 0.89 CCR5 (0.43) CCR5CCR2MMP1MMP9MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity VIROCHEM PHARMA INC (CA) 2005-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050075326-A1 Spiro compounds and methods for the modulation of chemokine receptor activity CXCR1, CXCR4, CXCR2 CCR5 4/4885CCR2 5/4885PDE4B 1290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.